In a large cohort of hospitalized patients in Maryland, it was found that Black patients with aortic stenosis had a ...
1. The Portico aortic valve had non-inferior rates of all-cause mortality and disabling stroke at 1 year after randomization compared ...
1. Patients with asymptomatic severe aortic stenosis receiving early valve replacement had a lower incidence of operative mortality or death ...
1. This randomized clinical trial showed that cerebral embolic protection devices did not significantly reduce the risk of CNS infarction ...
1. Among patients at intermediate surgical risk, transcatheter aortic valve replacement (TAVR) was shown to be noninferior to surgery with ...
1. Administration of fibrinogen concentrate in patients undergoing high-risk cardiac surgery did not significantly reduce intraoperative blood loss. Evidence Rating ...
1. Among all patients undergoing transcatheter aortic valve replacement, an increased risk of infective endocarditis was found in males, younger ...
1. The number and volume of new brain lesions was lower in patients with an implanted cerebral protection device following ...
1. For intermediate-risk surgical candidates with aortic stenosis, transcatheter aortic-valve replacement (TAVR) was non-inferior to surgical aortic-valve replacement based on ...
1. For patients aged 50-69 years, there was no significant difference in long-term survival when comparing bioprosthetic and mechanical aortic ...
